Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2006206573 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Gao, Ying-Duo; Caldwell, Charles G.; Scapin, Giovanna; Weber, Ann E.; Ashton, Wallace T.; Dong, Hong

Agent Spruson & Ferguson

Pub. Number AU-B-2006206573

PCT Pub. Number WO2006/078676

Priority 60/645,220 19.01.05 US

Filing date 18 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 12 May 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/44 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/14 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 255/04 (2006.01) Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/078676 Priority application(s): WO2006/078676

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

12 May 2011 Application Accepted

  Published as AU-B-2006206573

8 September 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206577-Polypeptides for inducing a protective immune response against Staphylococcus aureus

2006206567-Wagering game with enhancement feature for bonus-triggering event